Welcome to our dedicated page for Enovix SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix's regulatory disclosures and financial reporting.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported tax-related share dispositions. On July 8, 2026, a total of 4,295 shares of common stock were withheld at $5.13 per share to satisfy tax obligations tied to vesting restricted stock units. These are not open-market sales. Reported direct holdings after the transactions were 586,692 and 590,051 shares on two lines that reflect different mixes of vested and unvested RSUs and performance RSUs described in the footnotes.
Enovix Corp President and CEO Rajendra K. Talluri reported routine tax-withholding share dispositions tied to equity vesting. On July 8, 2026, a total of 17,959 shares of common stock were withheld at $5.13 per share to satisfy tax obligations upon vesting of restricted stock units. Following these transactions, Talluri continues to hold roughly about 3 million shares directly, including large amounts issuable from vested and unvested RSUs and performance RSUs.
Enovix Corporation is appointing Dr. Michael Vyvoda as Chief Operating Officer effective July 29, 2026, reporting to President and CEO Dr. Raj Talluri. He will oversee global manufacturing, supply chain and operations engineering as the company ramps high-volume battery production in Malaysia and Korea with R&D support from India.
Under his employment agreement, Dr. Vyvoda will receive a $440,000 annual base salary and an annual target bonus equal to 60% of salary. He is also being granted restricted stock units with a fair market value of $4.0 million that vest over time, plus $100,000 of fully vested RSUs. The agreement includes cash severance equal to nine months of base salary, continued health coverage, a pro-rated bonus and potential accelerated equity vesting if he is terminated without cause or resigns for good reason, with enhanced vesting protection in connection with a change of control.
The company highlights that in its first quarter 2026 results it grew revenue 49% year over year to $7.6 million, delivered a sixth consecutive quarter of positive gross profit and expanded its global pipeline for Korea-manufactured products to more than $130 million. Production is underway for silicon-anode batteries for smart eyewear following a commercial production order of approximately 50,000 units, while smartphone qualification and the new MX-1 platform for drone and defense markets continue to progress.
Enovix Corp Chief Accounting Officer Kristina Truong reported routine tax-related share dispositions tied to vesting stock awards. On 2026-07-01 and 2026-07-05, a total of 7,257 shares of common stock were withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units. These Form 4 transactions are coded as tax-withholding dispositions rather than open-market sales. Following the most recent transaction, Truong directly holds 307,097 shares of Enovix common stock, excluding additional unvested RSU and performance-based RSU awards referenced in the footnotes.
Enovix Corp’s Chief Financial Officer, Ryan A. Benton, reported a routine tax-related share disposition tied to equity compensation. On the vesting of restricted stock units (RSUs), 10,988 shares of common stock were withheld at $5.85 per share to cover tax withholding obligations.
After this withholding, Benton continues to hold 914,380 shares of Enovix common stock directly, including 827,255 shares issuable upon future vesting and settlement of RSUs that have been granted to him. This filing reflects compensation-related mechanics rather than an open-market stock sale.
Enovix Corp reports that Chief Legal Officer Chakravarthy Arthi had 10,368 shares of common stock withheld on July 1, 2026 to satisfy tax withholding obligations from vesting restricted stock units at $5.85 per share.
After these tax-withholding dispositions, the reporting person directly holds 590,987 shares of Enovix common stock, alongside unvested RSU and performance RSU awards scheduled to settle between 2027 and 2028.
Enovix Corp President and CEO Rajendra K. Talluri reported routine tax-withholding transactions related to equity compensation. On July 1, 2026, a total of 46,333 shares of common stock were withheld at $5.85 per share to satisfy tax obligations triggered by the vesting of restricted stock units. These Form 4 entries reflect payment of tax liability by delivering shares rather than an open-market sale, and are tied to previously granted RSUs and performance RSUs that continue to vest over future dates.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a small share disposition that reflects tax handling rather than an open-market trade. On this Form 4, 2,221 shares of common stock were withheld at $5.94 per share to satisfy tax obligations tied to vesting restricted stock units.
After this withholding, Chakravarthy is credited with 601,355 common shares, including 385,238 shares linked to unvested RSUs and additional performance RSUs scheduled for settlement between March 2027 and April 2028. The filing shows a routine compensation-related tax event, with the executive maintaining a substantial equity position.
Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition tied to equity compensation. On the reported date, 17,650 shares of common stock were withheld at $7.08 per share to cover tax obligations arising from vesting restricted stock units.
After this withholding, Talluri directly owned 3,044,616 shares of Enovix common stock. This total includes 1,956,490 shares issuable upon future vesting and settlement of RSUs, 47,775 vested performance RSUs scheduled for release in March 2027, and 259,611 additional PRSUs with releases in April 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported a routine tax-related share disposition. On the transaction date, 1,015 shares of common stock were withheld at $6.66 per share to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs).
After this withholding, Truong directly holds 314,354 shares of Enovix common stock. This total includes 218,694 shares issuable upon future vesting and settlement of RSUs and vested performance RSUs: 2,489 PRSUs scheduled for release in March 2027 and 35,278 PRSUs to be released in two tranches in April 2027 and April 2028.
The transaction is classified as a tax-withholding disposition rather than an open-market sale, and reflects standard equity compensation and tax treatment rather than a discretionary trade in Enovix shares.